Literature DB >> 28552139

Endovascular treatment of spinal arteriovenous malformations.

Waleed Brinjikji1, Giuseppe Lanzino2.   

Abstract

Spinal arteriovenous malformations (AVMs) are a rare but treatable cause of myelopathy and spinal cord hemorrhage. The clinical presentation and ideal treatment of these lesions vary widely, primarily due to differences in anatomic and angioarchitectural features. Six well-defined types of fistula have been defined: (1) intradural dorsal AVM; (2) intramedullary AVM; (3) extradural-intradural AVM; (4) intradural ventral AVF; (5) extradural/epidural AVF; and (6) conus medullaris AVM. Each of these lesions have unique clinical presentations and variable natural histories and endovascular treatment options. The principles of endovascular treatment include: (1) a complete understanding of the angioarchitecture and anatomic features of the lesion, including identification of radiculomedullary arteries; (2) careful spinal angiography; (3) identification of treatment goals prior to the procedure (i.e., complete occlusion versus partial occlusion aimed at altering natural history); (4) selection of proper embolic agent; and (5) careful follow-up in both the immediate postoperative setting and long term.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  embolization; endovascular; myelopathy; spinal arteriovenous malformation

Mesh:

Year:  2017        PMID: 28552139     DOI: 10.1016/B978-0-444-63640-9.00016-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  2 in total

1.  Cervical Radiculopathy Caused by Spinal Epidural Arteriovenous Fistula (SEDAVF) Without Intradural Drainage: A Case Report and Literature Review.

Authors:  Daewon Park; Donghan Kim; Dong-Hun Kang; Subum Lee; Dae-Chul Cho
Journal:  Korean J Neurotrauma       Date:  2022-02-17

2.  Spinal Vascular Shunts: Single-Center Series and Review of the Literature of Their Classification.

Authors:  Jafeth Lizana; Nelida Aliaga; Walter Marani; Amanda Escribano; Nicola Montemurro
Journal:  Neurol Int       Date:  2022-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.